Skip to main content
SpringerLink
Log in

Dasatinib

Persistent pleural effusion: 2 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Nagata Y, Fukuda S, Kobayashi T, Yamashita T, Ohashi K, Sakamaki H, Akiyama H.Safe switching from dasatinib to nilotinib after a 1-month off-drug period for persistent pleural effusion in patients with chronic myelogenous leukemia in chronic phase. International Journal of Hematology 91: 539-541, No. 3, Apr 2010. Available from: URL: http://dx.doi.org/10.1007/s12185-010-0526-8 - Japan

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dasatinib. React. Wkly. 1304, 15 (2010). https://doi.org/10.2165/00128415-201013040-00046

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201013040-00046

Keywords

Search

Navigation